Risk Stratification in Polycythemia Vera
Targeted Oncology Low-risk patients will benefit from phlebotomy to maintain their hematocrit below 45%. There are data supporting why hematocrit below 45% should be pursued. And everybody should get an aspirin. Again, the platelet count needs to be monitored in this ... |
from phlebotomy - Google News http://bit.ly/2pXnL0m
No comments:
Post a Comment